Prediction of Glucose Intolerance in Early Postpartum in Women with Gestational Diabetes Mellitus Based on the 2013 WHO Criteria
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Predictors for glucose intolerance postpartum were evaluated in women with gestational diabetes mellitus (GDM) based on the 2013 World Health Organization (WHO) criteria. 1841 women were tested for GDM in a prospective cohort study. A postpartum 75g oral glucose tolerance test (OGTT) was performed in women with GDM at 14 ± 4.1 weeks. Of all 231 mothers with GDM, 83.1% (192) had a postpartum OGTT of which 18.2% (35) had glucose intolerance. Women with glucose intolerance were more often of Asian origin [15.1% vs. 3.7%, OR 4.64 (1.26–17.12)], had more often a recurrent history of GDM [41.7% vs. 26.7%, OR 3.68 (1.37–9.87)], higher fasting glycaemia (FPG) [5.1 (4.5–5.3) vs. 4.6 (4.3–5.1) mmol/L, OR 1.05 (1.01–1.09)], higher HbA1c [33 (31–36) vs. 32 (30–33) mmol/mol, OR 4.89 (1.61–14.82)], and higher triglycerides [2.2 (1.9–2.8) vs. 2.0 (1.6–2.5) mmol/L, OR 1.00 (1.00–1.01)]. Sensitivity of glucose challenge test (GCT) ≥7.2 mmol/l for glucose intolerance postpartum was 80% (63.1%–91.6%). The area under the curve to predict glucose intolerance was 0.76 (0.65–0.87) for FPG, 0.54 (0.43–0.65) for HbA1c and 0.75 (0.64–0.86) for both combined. In conclusion, nearly one-fifth of women with GDM have glucose intolerance postpartum. A GCT ≥7.2 mmol/L identifies a high risk population for glucose intolerance postpartum.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In general, the IADPSG screening strategy identifies women with milder degrees of hyperglycemia during pregnancy compared to other diagnostic criteria and screening strategies (two-step or selective screening), which might lead to a lower proportion at risk of postpartum glucose intolerance [9,10,11].”
From The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis (2019) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In general, the IADPSG screening strategy identifies women with milder degrees of hyperglycemia during pregnancy compared to other diagnostic criteria and screening strategies (two-step or selective screening), which might lead to a lower proportion at risk of postpartum glucose intolerance [9,10,11].”
From The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis (2019) · cites this paper as [10]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“We have previously shown glucose intolerance in 42% of women three months after a pregnancy with GDM diagnosed by a two-step screening strategy with a GCT, while less than 20% of women had glucose intolerance in early postpartum after a GDM pregnancy based on a universal one-step diagnostic approach with the IADPSG criteria [9,10].”
From The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis (2019) · cites this paper as [10]
In the citing paper
“We have previously shown glucose intolerance in 42% of women three months after a pregnancy with GDM diagnosed by a two-step screening strategy with a GCT, while less than 20% of women had glucose intolerance in early postpartum after a GDM pregnancy based on a universal one-step diagnostic approach with the IADPSG criteria [9,10].”
From The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis (2019) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 1×
“The homeostasis model assessment of insulin resistance (HOMA-IR) and β-cell function (HOMA-B), were measured in early pregnancy, as previously described [17].”
MethodToprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Weight Gain During Pregnancy: Reexamining the Guidelines
Rasmussen, K. M., & Yaktine, A. L. (2009) · Cited by 4,473
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · cited 3×
“By diagnosing GDM, a group of women at high risk to develop T2DM and cardiovascular disease later in life was identified [4,5].”
BackgroundMethodEffect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 1×
“Treatment of GDM between 24–28 weeks of pregnancy can reduce adverse pregnancy outcomes, especially large-for-gestational age infants and preeclampsia [2,3].”
BackgroundMetzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.012 · Cited by 914
Lowe, W. L., Scholtens, D. M., Lowe, L. P., Kuang, A., Nodzenski, M., Talbot, O., Catalano, P. M., Linder, B., Brickman, W. J., Clayton, P., et al. (2018) · JAMA · doi:10.1001/jama.2018.11628 · Cited by 591
Gerstein, H. C., Santaguida, P., Raina, P., Morrison, K. M., Balion, C., Hunt, D., Yazdi, H., & Booker, L. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.05.004 · Cited by 575
Aroda, V. R., Christophi, C. A., Edelstein, S. L., Zhang, P., Herman, W. H., Barrett-Connor, E., Delahanty, L. M., Montez, M. G., Ackermann, R. T., Zhuo, X., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3761 · Cited by 467
Trying to understand gestational diabetes
Catalano, P. M. (2014) · Diabetic Medicine · doi:10.1111/dme.12381 · Cited by 456 · cited 1×
“However, women who develop GDM, often already have a subclinical metabolic dysfunction prior to conception compared with NGT women [37].”
BackgroundEvaluation of proposed oral disposition index measures in relation to the actual disposition index
Retnakaran, R., Qi, Y., Goran, M. I., & Hamilton, J. K. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02841.x · Cited by 320
Stumvoll, M., Van Haeften, T., Fritsche, A., & Gerich, J. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.796 · Cited by 308
Song, C., Lyu, Y., Li, C., Liu, P., Li, J., Ma, R. C., & Yang, X. (2018) · Obesity Reviews · doi:10.1111/obr.12645 · Cited by 293
Rayanagoudar, G., Hashi, A. A., Zamora, J., Khan, K. S., Hitman, G. A., & Thangaratinam, S. (2016) · Diabetologia · doi:10.1007/s00125-016-3927-2 · Cited by 292
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
Richter, B., Hemmingsen, B., Metzendorf, M.-I., & Takwoingi, Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012661.pub2 · Cited by 283
Clinically Useful Estimates of Insulin Sensitivity During Pregnancy
Kirwan, J. P., Huston-Presley, L., Kalhan, S. C., & Catalano, P. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1602 · Cited by 218
Ferrara, A., Peng, T., & Kim, C. (2009) · Diabetes Care · doi:10.2337/dc08-1184 · Cited by 209
Gunderson, E. P., Lewis, C. E., Lin, Y., Sorel, M., Gross, M., Sidney, S., Jacobs, D. R., Shikany, J. M., & Quesenberry, C. P. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.7978 · Cited by 164
Lawrence, J. M., Black, M. H., Hsu, J.-W., Chen, W., & Sacks, D. A. (2010) · Diabetes Care · doi:10.2337/dc09-2095 · Cited by 145
Elbein, S. C., Wegner, K., & Kahn, S. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.2.221 · Cited by 109 · cited 1×
“The Matsuda and Stumvoll indices were multiplied to calculate the oral disposition index, which assesses β-cell compensation for insulin resistance [23].”
MethodO'Reilly, M. W., Avalos, G., Dennedy, M. C., O'Sullivan, E. P., & Dunne, F. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0663 · Cited by 109
Benhalima, K., Van Crombrugge, P., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., De Block, C., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0556 · Cited by 85
Self-citationWL, J. L., DM, S., LP, L., A, K., M, N., O, T., PM, C., B, L., WJ, B., P, C., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.2.10 · Cited by 68
ATLANTIC DIP: simplifying the follow-up of women with previous gestational diabetes
Noctor, E., Crowe, C., Carmody, L. A., Avalos, G. M., Kirwan, B., Infanti, J. J., O'Dea, A., Gillespie, P., Newell, J., McGuire, B., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0491 · Cited by 54
Benhalima, K., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., Block, C. E. M. D., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100351 · Cited by 49
Self-citationGlucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria
Benhalima, K., Jegers, K., Devlieger, R., Verhaeghe, J., & Mathieu, C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157272 · Cited by 45
Self-citationBenhalima, K., Van Crombrugge, P., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Dufraimont, E., De Block, C., Jacquemyn, Y., Mekahli, F., et al. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-226 · Cited by 43
Self-citationLeuridan, L., Wens, J., Devlieger, R., Verhaeghe, J., Mathieu, C., & Benhalima, K. (2015) · Primary care diabetes · doi:10.1016/j.pcd.2015.03.007 · Cited by 40
Self-citationChittleborough, C., Baldock, K. L., Taylor, A. W., Hague, W. M., Willson, T., Martin, W., Jenny, W. O. O. D., & Phillips, P. J. J. (2010) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2010.01140.x · Cited by 36
Benhalima, K., Verstraete, S., Muylle, F., Decochez, K., Devlieger, R., Crombrugge, P. V., Verhaegen, A. A., Wens, J., & Mathieu, C. (2017) · International Journal of Endocrinology · doi:10.1155/2017/3971914 · Cited by 27
Self-citationWerbrouck, A., Schmidt, M., Putman, K. D., Benhalima, K., Verhaeghe, N., Annemans, L., & Simoens, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.11.012 · Cited by 22
Self-citationKim, K., Kim, S. ‐., Cho, Y. ‐., & Park, S. (2016) · Diabetic Medicine · doi:10.1111/dme.13119 · Cited by 13
Kapaya, H., May, L. S., Jacques, R., & Madhuvrata, P. (2017) · Obstetric Medicine · doi:10.1177/1753495x17702786 · Cited by 5
Cited by
Benhalima, K., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., Block, C. E. M. D., et al. (2020) · Acta Diabetologica · doi:10.1007/s00592-019-01469-5 · Cited by 60
Self-citationBenhalima, K., Lens, K., Bosteels, J., & Chantal, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091431 · Cited by 50
“We have previously shown glucose intolerance in 42% of women three months after a pregnancy with GDM diagnosed by a two-step screening strategy with a GCT, while less than 20% of women had glucose intolerance in early postpartum after a GDM pregnancy based on a universal one-step diagnostic approach with the IADPSG cr…”
MethodSelf-citationLinnenkamp, U., Greiner, G. G., Haastert, B., Adamczewski, H., Kaltheuner, M., Weber, D., & Icks, A. (2022) · Diabetic Medicine · doi:10.1111/dme.14861 · Cited by 44
Hasain, Z., Ali, R. A. R., Ahmad, H. F., Rauf, U. F. A., Oon, S. F., & Mokhtar, N. M. (2022) · Nutrients · doi:10.3390/nu14183878 · Cited by 49
Benhalima, K., Geerts, I., Calewaert, P., Rijsselberghe, M. V., Lee, D., Bochanen, N., Verstraete, S., Buyse, L., Lewi, L., Caron, R., et al. (2024) · Acta Clinica Belgica · doi:10.1080/17843286.2024.2384258 · Cited by 38
Self-citation
Metadata
- Authors
- Benhalima, K., Van Crombrugge, P., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., De Block, C., Jacquemyn, Y., Mekahli, F., De Clippel, K., Van Den Bruel, A., Loccufier, A., Laenen, A., Minschart, C., Devlieger, R., & Mathieu, C.
- Affiliations
- KU Leuven (BE)
- Department of Endocrinology, OLV Ziekenhuis Aalst-Asse-Ninove, Moorselbaan 164, 9300 Aalst, Belgium
- Onze Lieve Vrouwziekenhuis Hospital (BE)
- Imelda Hospital (BE)
- Department of Endocrinology-Diabetology-Metabolism, Antwerp University Hospital, Wilrijkstraat 10, 2560 Edegem, Belgium
- Antwerp University Hospital (BE)
- Department of Endocrinology, Kliniek St-Jan Brussel, Kruidtuinlaan 32, 1000 Brussel, Belgium
- Department of Obstetrics & Gynecology, Kliniek St-Jan Brussel, Kruidtuinlaan 32, 1000 Brussel, Belgium
- Department of Endocrinology, AZ St Jan Brugge, Ruddershove 10, 8000 Brugge, Belgium
- AZ Sint-Jan (BE)
- Corresponding author
- Benhalima, Katrien
- ORCID
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2019-03-19
- Volume
- 8
- Issue
- 3
- Pages
- 383
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC6462976
- OpenAlex
- W2924376817
- Cited by
- 33
- References
- 43
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 3 · 2020: 5 · 2019: 2
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lirias (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- the Belgian National Lottery (NA)
- the Fund of Academic studies of UZ Leuven (NA)
- the Fund Yvonne and Jacques François - de Meurs of the King Boudewijn Foundation. (NA)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- postpartum glucose intolerance, oral glucose tolerance test, glucose challenge test, fasting blood glucose, HbA1c, triglycerides, Asian ethnicity, recurrent gestational diabetes, risk prediction, postpartum women, prediabetes screening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.